Ani Pharmaceuticals (ANIP) Total Debt (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Total Debt of $305.3 million for Q1 2026, down 1.23% sequentially from $309.1 million in Q4 2025, and down 3.54% YoY from $316.5 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Total Debt (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Total Debt for 15 years, with the latest figure at $305.3 million in Q1 2026.
- Quarterly Total Debt fell 3.54% year-over-year to $305.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305.3 million (down 3.54% YoY) and the FY2025 annual result came in at $309.1 million, down 2.88% from the prior year.
- Total Debt declined to $305.3 million in Q1 2026 per ANIP's latest filing, from $309.1 million in the prior quarter.
- Over five years, Total Debt peaked at $318.3 million in Q4 2024 and troughed at $285.0 million in Q1 2024.
- A 5-year average of $297.1 million and a median of $287.2 million in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2026: Total Debt jumped 56.55% in 2022, then fell 3.54% in 2026.
- Over 5 years, Total Debt stood at $285.7 million in 2022, then climbed by 4.0% to $297.1 million in 2023, then increased by 7.13% to $318.3 million in 2024, then retreated by 2.88% to $309.1 million in 2025, then decreased by 1.23% to $305.3 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $305.3 million, $309.1 million, and $312.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 301.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 301.48 Mn |
| Mar 31, 2026 | 305.29 Mn |
| Dec 31, 2025 | 309.11 Mn |
| Sep 30, 2025 | 312.92 Mn |
| Jun 30, 2025 | 301.97 Mn |
| Mar 31, 2025 | 316.49 Mn |
| Dec 31, 2024 | 318.28 Mn |
| Sep 30, 2024 | 314.20 Mn |
| Jun 30, 2024 | 285.24 Mn |
| Mar 31, 2024 | 285.02 Mn |
| Dec 31, 2023 | 297.09 Mn |
| Sep 30, 2023 | 285.88 Mn |
| Jun 30, 2023 | 286.09 Mn |
| Mar 31, 2023 | 286.31 Mn |
| Dec 31, 2022 | 285.67 Mn |
| Sep 30, 2022 | 286.73 Mn |
| Jun 30, 2022 | 286.95 Mn |
| Mar 31, 2022 | 287.16 Mn |
| Dec 31, 2021 | 287.37 Mn |
| Sep 30, 2021 | 201.99 Mn |